跳至主要内容
临床试验/NCT03682250
NCT03682250终止不适用

Electrocardiographic Modifications During Spontaneous Hypoglycemic Episodes in Patients with Type 1 Diabetes At High Cardiovascular Risk

Institut de Recherches Cliniques de Montreal1 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2018年9月17日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
29
试验地点
1
主要终点
QT intervals corrected for heart rate

研究概览

简要总结

The population of type 1 diabetes patients with cardiovascular disease is increasing and this study aims to explore the electrocardiographic changes that are associated with spontaneous hypoglycemia in this type of population. More precisely, this study will investigate if these modifications are of the same nature as those already observed in different populations (patients with type 2 diabetes) to see the pro-arrhythmogenic impact of hypoglycemia in patients with type 1 diabetes.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and women ≥ 18 years old;
  • Be able to give informed consent;
  • Diagnosis of type 1 diabetes for ≥ 6 months;
  • Treated with intensive insulin therapy (multiple injections of insulin or insulin pump)
  • A history of CV disease defined as: 1) Established diagnosis of atherosclerotic coronary artery disease (example: previous history of infarction); 2) Previous cerebral Vascular Stroke or Transient Ischemic Accident; 3) Anterior revascularization of the coronary arteries, carotid artery or peripheral arteries; 4) At least one coronary stenosis, carotid artery or lower extremity arteries > 50%; 5) History of symptomatic coronary heart disease confirmed with hospitalization or a positive stress test result or by any cardiac imaging result, or unstable angina with changes observed at the ECG; 6) Asymptomatic cardiac ischemia confirmed by a nuclear imaging test, an exercise test, a dobutamine stress echo; 7) NYHA II-III class chronic heart failure; 8) Amputation of limb or foot due to circulatory insufficiency.
  • Or more than 20 years duration of T1D and at least 2 of the following risk factors or associated condition: 1) Chronic renal failure eGFR <60 ml / min / 1.73 m2); 2) Presence of micro or macro-albuminuria (albumin / creatinine ratio > 2); 3) Hypertension or treatment for hypertension; 4) Hyperlipidemia or treatment for hypolipemia; 5) Abdominal obesity (Waist circumference> 94 cm for men and > 80 cm for women); 6) Smoking ; 7) Significant retinopathy (pre-proliferative, proliferating, laser or intravitreous injection); 8) Body mass index > 30 kg /m2; 9) Erectile dysfunction; 10) Left ventricular hypertrophy; 11) Positive family history of early MCAS (H < 55 years old and F < 65 years old)

排除标准

  • Definitive criteria: 1) QRS > 120 ms on the baseline ECG; 2) Presence of atrial fibrillation at inclusion; 3) Current intake of any drug that may prolong QT according to the judgment of the investigator and the update of the list available on www.professionsante.com.
  • Transient criteria (the patient can be included once the anomaly is corrected): 1) Hypokalemia (< 3.5 mmol/L); 2) Hypocalcemia (ionized calcium < 1.10 mmol/L); 3) Hypomagnesemia (< 0.7 mmol/L)

结局指标

主要结局

QT intervals corrected for heart rate

时间窗: 48 hours

次要结局

  • Percentage of time between 4.0 and 10.0 mmol/L(48 hours)
  • Percentage of time below 3.5 mmol/L(48 hours)

研究者

发起方
Institut de Recherches Cliniques de Montreal
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rémi Rabasa-Lhoret

Full professor

Institut de Recherches Cliniques de Montreal

研究点 (1)

Loading locations...

相似试验

Electrocardiographic Modifications and Spontaneous... | 临床试验